Allergan Aesthetics: TrenibotE & GLP-1 Patient Data at AAD 2026

Allergan Aesthetics: TrenibotE & GLP-1 Patient Data at AAD 2026

March 30, 2026

The intersection of aesthetic medicine and broader health trends is becoming increasingly apparent, and the data presented at the American Academy of Dermatology (AAD) meeting this week underscores that connection. Allergan Aesthetics, an AbbVie company, highlighted not only advancements in neurotoxin technology like TrenibotE, but also the growing impact of GLP-1 agonists – medications initially designed for weight loss – on patient behavior within aesthetic clinics. This isn’t just about cosmetic enhancements anymore; it’s about understanding the holistic impact of metabolic changes on facial appearance and patient expectations, a trend that’s likely to be felt acutely here in Chicago.

TrenibotE: A Potential Game-Changer in Neurotoxin Treatments

The buzz around TrenibotE (trenibotulinumtoxinE) is significant. What sets it apart isn’t just its investigational status, but its speed of onset – visible results as early as eight hours after administration – and a relatively short duration of effect, around two to three weeks. This could be a major shift for patients seeking more control and flexibility with their treatments. The Phase 3 study data presented at AAD showed a consistent safety profile over repeat treatments, which is crucial for building patient trust and long-term adherence. For Chicagoans, who often lead busy, fast-paced lives, the promise of quicker results with a manageable treatment window could be particularly appealing. The fact that no neutralizing antibodies were developed during the study is also a positive sign, suggesting sustained responsiveness to the treatment.

The GLP-1 Agonist Effect: A New Demographic in Aesthetic Clinics

Perhaps the more surprising revelation from the AAD presentations concerns the influx of patients using GLP-1 agonists – like Ozempic and Wegovy – into aesthetic practices. Allergan Aesthetics’ data indicates that over 52% of patients undergoing GLP-1 treatment express concerns about their facial appearance as they lose weight. This isn’t entirely unexpected; rapid weight loss can lead to volume loss in the face, resulting in a more gaunt or aged appearance. What’s noteworthy is the scale of this phenomenon. The study found that 32% of GLP-1 treated patients are *new* to aesthetic practices, representing a significant expansion of the potential patient base. Here in Chicago, with its diverse population and growing awareness of both weight management and aesthetic options, we’re likely to see this trend play out prominently. The University of Chicago Medicine, for example, has been at the forefront of both GLP-1 research and advanced aesthetic procedures, positioning them to address this evolving patient need.

Barriers to Aesthetic Treatment for GLP-1 Patients

Interestingly, the study also identified key barriers preventing GLP-1 patients from pursuing aesthetic treatments. Cost (82%) was the primary concern, followed by fear of unnatural-looking results (58%). This highlights the need for accessible financing options and a focus on natural-looking enhancements. Practitioners in Chicago, known for their artistry and commitment to subtle results, are well-positioned to address these concerns. The demographic profile of these patients – predominantly white (64%), female (70%), and aged 30-49 (56%) – provides valuable insights for targeted marketing and service development. Organizations like the Illinois Society of Dermatology and Dermatologic Surgery could play a role in educating both practitioners and patients about the interplay between weight loss and facial aesthetics.

Navigating the Changing Landscape: A Local Resource Guide for Chicago Residents

Given my background in medical journalism and observing the evolving aesthetic landscape, if this trend impacts you in the Chicago area, here are three types of local professionals you should consider consulting:

  • Board-Certified Dermatologists with Aesthetic Specialization: Look for dermatologists who are fellowship-trained in aesthetic medicine and have extensive experience with both injectables (like Botox and fillers) and energy-based devices. They should prioritize a natural-looking approach and be able to tailor treatments to your individual facial anatomy. Verify their board certification through the American Board of Dermatology.
  • Experienced Registered Nurses (RNs) under Dermatologist Supervision: Many excellent aesthetic treatments are safely and effectively administered by RNs working under the direct supervision of a board-certified dermatologist. Ensure the RN has specific training and certification in aesthetic procedures and a proven track record of positive patient outcomes.
  • Facial Plastic Surgeons Focused on Non-Surgical Options: While surgical procedures are an option, many facial plastic surgeons also offer a range of non-surgical treatments to address volume loss and facial aging. Look for surgeons who are board-certified by the American Board of Facial Plastic and Reconstructive Surgery and who emphasize a conservative, natural approach.

Ready to find trusted professionals? Browse our complete directory of top-rated aesthetic experts in the Chicago area today.